The new list of discounted drugs includes an anticoagulant, a beta-blocker used to treat atrial fibrillation and much more. 

The new algorithm from Tempus AI evaluates 12-lead ECG results, alerting users when a patient could be at risk of experiencing AFib within the next 12 months.

Grocery stores have started selling more and more plant-based meat alternatives in recent years, and early evidence suggests replacing even some meat with these products may be beneficial. Researchers did note that more studies on this subject are still needed.

Some care teams have turned to a more active follow-up strategy for high-risk PCI patients—but it may not provide much value. 

Persistent and paroxysmal atrial fibrillation appear to affect short- and long-term TAVR mortality rates in different ways, according to a new study of nearly 3,000 patients. Some trends fade over time, while others remain in place after many years. 

Individuals with underlying heart disease may want to avoid energy drinks going forward, according to a new Mayo Clinic analysis.

Teva Pharmaceuticals has officially launched generic liraglutide injections in the United States. Novo Nordisk currently sells liraglutide under the brand name Victoza.

Veteran cardiologist Harlan M. Krumholz, MD, has a long history in medical research as both an author and an editor. He and his team want to review manuscripts quickly and publish a wide variety of voices.